CellGenix develops, manufactures and markets cell and protein therapeutics for tumor and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing. The company owns Metreon Bioproducts GmbH, which was founded in 1996 as a joint venture together with Schering AG. CellGenix also owns shares in American Fluoroseal Cooperation in Gaithersburg, Md., and in CellPrep S.A. in Buenos Aires.

The XCell-Center is a private clinic group and institute for regenerative medicine located in Düsseldorf and Cologne, Germany. Bringing together therapeutical use of autologous adult stem cells and medical research, it is our mission to: •Provide therapeutic application of autologous adult stem cells to patients at the highest medical standard; •Extend existing knowledge on the effects of autologous adult stem cells by supporting pre-clinical and clinical research. We offer patients with degenerative diseases the opportunity to undergo an innovative and promising stem cell treatment.

Axiogenesis AG is an innovative biotech company with expertise in applied stem cell technology.

t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiac or peripheral vascular diseases like myocardial infarction or peripheral artery occlusive disease.